Mosunetuzumab Interactions
There are 245 drugs known to interact with mosunetuzumab. Of the total drug interactions, 34 are major, 196 are moderate, and 15 are minor.
Medications known to interact with mosunetuzumab
Note: Showing generic names only.
- abrocitinib
- adalimumab
- ado-trastuzumab emtansine
- alefacept
- alemtuzumab
- alfentanil
- allogeneic processed thymus tissue
- aminophylline
- amiodarone
- anakinra
- apixaban
- astemizole
- atezolizumab
- atomoxetine
- atorvastatin
- auranofin
- aurothioglucose
- avelumab
- axicabtagene ciloleucel
- azathioprine
- baricitinib
- bcg
- belimumab
- benznidazole
- bifidobacterium infantis
- bifidobacterium longum
- bortezomib
- brentuximab
- brewer's yeast
- brexpiprazole
- brexucabtagene autoleucel
- cabazitaxel
- canakinumab
- carbamazepine
- carboplatin
- carfilzomib
- cemiplimab
- cerivastatin
- certolizumab
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- chloroquine
- ciltacabtagene autoleucel
- cinoxacin
- ciprofloxacin
- cisapride
- cisplatin
- cladribine
- clozapine
- colchicine
- cosibelimab
- crizotinib
- cyclosporine
- dapsone
- deferiprone
- delafloxacin
- denosumab
- deucravacitinib
- dicumarol
- didanosine
- dihydroergotamine
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- disopyramide
- disulfiram
- docetaxel
- dostarlimab
- dronedarone
- durvalumab
- dyphylline
- efalizumab
- efbemalenograstim alfa
- eflapegrastim
- eliglustat
- elotuzumab
- elranatamab
- enfortumab vedotin
- enoxacin
- ergotamine
- eribulin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etrasimod
- etravirine
- everolimus
- ezogabine
- idecabtagene vicleucel
- infliximab
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- iodoquinol
- ipilimumab
- isoniazid
- ixabepilone
- ixazomib
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- levodopa
- levofloxacin
- lidocaine
- linezolid
- lisocabtagene maraleucel
- lomefloxacin
- loncastuximab tesirine
- lovastatin
- lurbinectedin
- mephenytoin
- mesoridazine
- methadone
- metronidazole
- mexiletine
- mirvetuximab soravtansine
- monomethyl fumarate
- moxifloxacin
- nadofaragene firadenovec
- nalidixic acid
- natalizumab
- naxitamab
- nelarabine
- niraparib
- nitrofurantoin
- nivolumab
- norfloxacin
- paclitaxel
- paclitaxel protein-bound
- palifermin
- pegfilgrastim
- peginterferon alfa-2a
- peginterferon alfa-2b
- pembrolizumab
- penpulimab
- phenobarbital
- phenytoin
- pimozide
- pitavastatin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- ponesimod
- pravastatin
- primidone
- procainamide
- propafenone
- radium 223 dichloride
- red yeast rice
- repotrectinib
- retifanlimab
- rilonacept
- ritlecitinib
- rivaroxaban
- roflumilast
- ropeginterferon alfa-2b
- rosuvastatin
- ruxolitinib topical
- saccharomyces boulardii lyo
- samarium sm 153 lexidronam
- sargramostim
- secnidazole
- selinexor
- simvastatin
- siponimod
- sipuleucel-T
- sirolimus
- sodium phosphate p32
- sparfloxacin
- stavudine
- streptococcus salivarius
- strontium-89 chloride
- sunitinib
- tacrolimus
- talquetamab
- tarlatamab
- tbo-filgrastim
- teclistamab
- telbivudine
- temsirolimus
- teniposide
- terfenadine
- teriflunomide
- thalidomide
- theophylline
- thioridazine
- tinidazole
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tizanidine
- tocilizumab
- tofacitinib
- topotecan
- toripalimab
- trabectedin
- tremelimumab
- trovafloxacin
Report options
More about mosunetuzumab
- mosunetuzumab consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Monjuvi
Monjuvi (tafasitamab-cxix) is used for the treatment of relapsed or refractory diffuse large B-cell ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma, two types of non-Hodgkin ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
